Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Morgan

Showing results (971-980 of 1,038) with videos related to

Pageof 104
Sort By:
Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
NPJ Breast Cancer|February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
The Lancet. Oncology|May 8, 2007
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Matthew R Sydes, John D Graham, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Current Biology : CB|July 4, 2020
Input Connectivity Reveals Additional Heterogeneity of Dopaminergic Reinforcement in DrosophilaNils Otto, Markus W Pleijzier, Isabel C Morgan, et al.
Arquivos De Neuro-Psiquiatria|May 18, 2026
True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's diseaseJoseph H Friedman, Umer Akbar, Blake Beehler, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series AnalysisEalia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
JAMA Network Open|August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN TrialsSoumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Nature Communications|March 6, 2020
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertensionHebah A Sindi, Giusy Russomanno, Sandro Satta, et al.
Pageof 104

Showing results (971-980 of 1,038) with videos related to

Sort By:
Pageof 104
Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
NPJ Breast Cancer|February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
The Lancet. Oncology|May 8, 2007
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Matthew R Sydes, John D Graham, et al.
BJUI Compass|August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based studyShawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
Current Biology : CB|July 4, 2020
Input Connectivity Reveals Additional Heterogeneity of Dopaminergic Reinforcement in DrosophilaNils Otto, Markus W Pleijzier, Isabel C Morgan, et al.
Arquivos De Neuro-Psiquiatria|May 18, 2026
True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's diseaseJoseph H Friedman, Umer Akbar, Blake Beehler, et al.
The Lancet. Oncology|November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series AnalysisEalia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
JAMA Network Open|August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN TrialsSoumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Nature Communications|March 6, 2020
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertensionHebah A Sindi, Giusy Russomanno, Sandro Satta, et al.
Pageof 104